
U.S. pathology labs are now awash in COVID-19 tests, with more than two dozen rapid tests on the market thanks to expedited approval by the U.S. Food and Drug Administration, infectious disease experts say. Despite this, laboratories are still struggling with shortages that hamper their ability to get ahead of the ever-expanding pandemic. “Early in… read on >